[Effect of insulin and beta-adrenergic blockaders on coronary circulation in response to hypoxia]. 1983

A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret

An experimental study in dogs with intact thoracic cavity under morphine-chloralose narcosis featured coronary catheterization, extracorporeal perfusion and resistography as well as catheterization of the heart cavities and the coronary sinus. Hemodynamic and respiratory parameters were recorded simultaneously. PO2, PCO2 and pH were measured in the inflowing and outflowing blood. The effect of insulin on circulatory response in acute hypoxic hypoxia was examined before and after obsidan block of beta-adrenoreactive systems. Insulin administered after the obsidan beta-adrenergic block was found to limit coronary dilatation and reduce myocardial oxygen consumption in a more pronounced measure. It is suggested that the effect of insulin on coronary dilatation is due to reduced myocardial oxygen consumption resulting from its action on the heart's beta-adrenergic systems.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
November 1971, Kardiologiia,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
January 1980, Archivos del Instituto de Cardiologia de Mexico,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
January 1971, Naunyn-Schmiedebergs Archiv fur Pharmakologie,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
December 1972, Folia endocrinologica,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
December 1971, Medizinische Klinik,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
April 1971, La Presse medicale,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
January 1982, Terapevticheskii arkhiv,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
February 1975, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A I Khomaziuk, and L F Iakusheva, and L A Iavorskiĭ, and A P Neshcheret
March 1969, Terapevticheskii arkhiv,
Copied contents to your clipboard!